This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the mechanisms, current uses, and emerging evidence for GLP-1 receptor agonists in the treatment of substance use disorders, including nicotine, stimulants, and alcohol.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the prevalence and risks of alcohol use during pregnancy, management of acute withdrawal, and evidence-based treatment strategies for alcohol use disorder in the perinatal period.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses current research priorities in addiction medicine, emerging areas for future funding, and the value of collaboration between scientific and clinical communities to enhance care and health equity.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses key aspects of alcohol use, including standard drink sizes, signs and risks of Alcohol Withdrawal Syndrome, and strategies for developing comprehensive, patient-centered treatment plans for alcohol use disorder.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses evidence-based approaches to outpatient alcohol withdrawal management, including multidisciplinary strategies and the development of tailored clinical protocols.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the history and efficacy of Alcoholics Anonymous (AA) in treating AUD, dispelling common myths, and bridging the gap between clinical practice and self-help approaches, aiming to enhance providers' confidence in recommending AA as part of a holistic treatment plan, ultimately leading to improved patient outcomes and broader recovery success.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the most impactful addiction medicine publications from 2024-2025, their integration into clinical practice, and the influence of media coverage on their reach and relevance.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course covers most recent updates on emerging issues and advances in addiction medicine from the perspective of three major federal agencies: NIAAA, SAMHSA, and NIDA.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course examines new research on AUD treatment, including spironolactone, psychedelics, GLP-1, and technology-assisted approaches.